Altered default network resting state functional connectivity in patients with a first episode of psychosis
- PMID: 22633527
- PMCID: PMC3393844
- DOI: 10.1016/j.schres.2012.05.005
Altered default network resting state functional connectivity in patients with a first episode of psychosis
Abstract
Background: Default network (DN) abnormalities have been identified in patients with chronic schizophrenia using "resting state" functional magnetic resonance imaging (R-fMRI). Here, we examined the integrity of the DN in patients experiencing their first episode of psychosis (FEP) compared with sex- and age-matched healthy controls.
Methods: We collected R-fMRI data from 19 FEP patients (mean age 24.9 ± 4.8 yrs, 14 males) and 19 healthy controls (26.1 ± 4.8 yrs, 14 males) at 3T. Following standard preprocessing, we examined the functional connectivity (FC) of two DN subsystems and the two DN hubs (P<0.0045, corrected).
Results: Patients with FEP exhibited abnormal FC that appeared largely restricted to the dorsomedial prefrontal cortex (dMPFC) DN subsystem. Relative to controls, FEP patients exhibited weaker positive FC between dMPFC and posterior cingulate cortex (PCC) and precuneus, extending laterally through the parietal lobe to the posterior angular gyrus. Patients with FEP exhibited weaker negative FC between the lateral temporal cortex and the intracalcarine cortex, bilaterally. The PCC and temporo-parietal junction also exhibited weaker negative FC with the right fusiform gyrus extending to the lingual gyrus and lateral occipital cortex, in FEP patients, compared to controls. By contrast, patients with FEP showed stronger negative FC between the temporal pole and medial motor cortex, anterior precuneus and posterior mid-cingulate cortex.
Conclusions: Abnormalities in the dMPFC DN subsystem in patients with a FEP suggest that FC patterns are altered even in the early stages of psychosis.
Copyright © 2012 Elsevier B.V. All rights reserved.
Conflict of interest statement
Anna Alonso Solís reports no biomedical financial interests or potential conflicts of interest. Dr. Corripio reports no biomedical financial interests or potential conflicts of interest. Dr. de Castro-Manglano has received research funding from: Alicia Koplowitz Fundation, AstraZeneca, Shire, Pfizer, Sociedad Vasco-Navarra de Psiquiatría, Govierno de Navarra. She has received Royalties from Ed. Médica Panamericana and EUNSA. Dr. Duran-Sindreu received lecture fees from Novartis and Actelion. Dr. García reports no biomedical financial interests or potential conflicts of interest. Dr. Proal reports no biomedical financial interests or potential conflicts of interest. Fidel Nuñez Marín reports no biomedical financial interests of potential conflicts or interest.
Dr. Soutullo has received research funding from: Abbott, Alicia Koplowitz Foundation, Bristol-Myers Squibb, Eli Lilly, Gobierno de Navarra, Carlos III Institute(FIS): Redes Temáticas de Investigación Cooperativa, Pfizer, PIUNA, Stanley Medical Research Institute-NAMI, and Solvay.
He has served as Consultant for: Alicia Koplowitz Foundation, Bristol-Myers Squibb, Editorial Médica Panamericana, Eli Lilly, Juste, EINAQ (European Interdisciplinary Network ADHD Quality Assurance), Janssen-Cilag, Pfizer, Shire, and Otsuka. He has served on the speaker's bureaus of : Asociación Navarra ADHI, ACANPADAH, APNADAH, AstraZeneca, ASTTA, Asociación Sarasate, TDAHGC, CC.AA.: Asturias, Canarias, Castilla y León, Madrid; Eli Lilly, Fundación Innovación Social de la Cultura, GlaxoSmithKline, Grupo Aula Médica, Janssen-Cilag, Novartis, SEP-SEPB, Shire, Sociedad Vasco-Navarra Psiquiatría, and Solvay. He has received Royalties from: DOYMA, Editorial Médica Panamericana, Grupo Correo, EUNSA, and Euro RSCG Life Medea Enric Alvarez has received consulting and educational honoraria from several pharmaceutical companies including Eli Lilly Sanofi-Aventis, Lundbeck and Pfizer, and he has participated as main local investigator in clinical trials from Eli Lilly, Bristol-Myers and Sanofi-Aventis and also as national coordinator of clinical trials from Servier and Lundbeck. Beatriz Gómez Ansón reports no biomedical financial interests or potential conflicts of interest. Dr. Kelly reports no biomedical financial interests or potential conflicts of interest. F. Xavier Castellanos reports no biomedical financial interests or potential conflicts of interest.
Figures
References
-
- Andersson J, Jenkinson M, Smith S. Non-linear optimisation (FMRIB Technical Report TR07JA1) FMRIB Centre; Oxford, United Kingdom: 2007a.
-
- Andersson J, Jenkinson M, Smith S. Non-linear registration, aka Spatial normalisation (FMRIB Technical Report TR07JA2) FMRIB Centre; Oxford, United Kingdom: 2007b.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
